Prospective, Phase II Randomized Study to Compare Busulfan-fludarabine Reduced-intensity Conditioning (RIC) With Thiotepa-fludarabine RIC Regimen Prior to Allogeneic Transplantation of Hematopoietic Cells for the Treatment of Myelofibrosis
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Fludarabine (Primary) ; Thiotepa (Primary) ; Busulfan
- Indications Myelofibrosis
- Focus Therapeutic Use
- 30 Mar 2017 Status changed from to completed.
- 08 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
- 05 Jul 2016 Planned End Date changed from 1 Jul 2017 to 1 Dec 2016.